Reported or theoretically plausible side effects of CJC 1295 and ipamorelin include: Water retention and peripheral oedema Flushing, headache, and dizziness, particularly after injection Tingling or numbness in the extremities Elevated IGF-1 levels, which over time may theoretically increase the risk of certain cancers, though a direct causal link has not been established in clinical studies [13] [14] Impaired glucose tolerance or insulin resistance GH excess and GH secretagogues are more commonly associated with raised blood glucose rather than hypoglycaemia
Uncontrolled type 2 diabetes, active gestational diabetes, or a recent hypoglycaemic event are reasons to avoid this compound entirely without direct clinical oversight
Injection site reactions occurred in a small percentage of participants
Arthritis Foundation: Omega-3 Fatty Acids for Your Health British Heart Foundation: What Is Calcification of the Arteries, and How Can I Treat It? Cleveland Clinic: Low Blood Pressure (Hypotension) Cleveland Clinic: What Can Magnesium Do for Your Body? Harvard Health Publishing: What Can Magnesium Do for You and How Much Do You Need? Journal of Personalized Medicine: Omega-3 Fatty Acids Supplementation in the Treatment of Depression: An Observational Study Journal of the American Heart Association: Effects of Magnesium Citrate, Magnesium Oxide, and Magnesium Sulfate Supplementation on Arterial Stiffness: A Randomized, DoubleBlind, PlaceboControlled Intervention Trial Journal of the American Heart Association: Nonprescription Magnesium Supplement Use and Risk of Heart Failure in Patients With Diabetes: A Target Trial Emulation Keck Medicine of USC: Is Magnesium Good for Your Health

Quercetin inhibitory activity directly affects mast cells, stabilizing them and reducing mediator release by the inhibition of the Ca 2+ influx, histamine, leukotrienes, prostaglandins, and activation of protein kinase [38,39]
Therefore, it was postulated that due to the extensive TCR cross-reactivity environmental antigens may induce autoimmune diseases by stimulating potentially autoreactive T cells (22)